Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

453 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The effect of tibolone and continuous combined conjugated equine oestrogens plus medroxyprogesterone acetate on progression of carotid intima-media thickness: the Osteoporosis Prevention and Arterial effects of tiboLone (OPAL) study.
Bots ML, Evans GW, Riley W, McBride KH, Paskett ED, Helmond FA, Grobbee DE; OPAL Investigators. Bots ML, et al. Among authors: paskett ed. Eur Heart J. 2006 Mar;27(6):746-55. doi: 10.1093/eurheartj/ehi695. Epub 2006 Jan 16. Eur Heart J. 2006. PMID: 16415304 Clinical Trial.
Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy.
Stefanick ML, Anderson GL, Margolis KL, Hendrix SL, Rodabough RJ, Paskett ED, Lane DS, Hubbell FA, Assaf AR, Sarto GE, Schenken RS, Yasmeen S, Lessin L, Chlebowski RT; WHI Investigators. Stefanick ML, et al. Among authors: paskett ed. JAMA. 2006 Apr 12;295(14):1647-57. doi: 10.1001/jama.295.14.1647. JAMA. 2006. PMID: 16609086 Clinical Trial.
Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial.
LaCroix AZ, Chlebowski RT, Manson JE, Aragaki AK, Johnson KC, Martin L, Margolis KL, Stefanick ML, Brzyski R, Curb JD, Howard BV, Lewis CE, Wactawski-Wende J; WHI Investigators. LaCroix AZ, et al. JAMA. 2011 Apr 6;305(13):1305-14. doi: 10.1001/jama.2011.382. JAMA. 2011. PMID: 21467283 Free PMC article. Clinical Trial.
Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women.
Chlebowski RT, Anderson GL, Gass M, Lane DS, Aragaki AK, Kuller LH, Manson JE, Stefanick ML, Ockene J, Sarto GE, Johnson KC, Wactawski-Wende J, Ravdin PM, Schenken R, Hendrix SL, Rajkovic A, Rohan TE, Yasmeen S, Prentice RL; WHI Investigators. Chlebowski RT, et al. JAMA. 2010 Oct 20;304(15):1684-92. doi: 10.1001/jama.2010.1500. JAMA. 2010. PMID: 20959578 Free PMC article. Clinical Trial.
Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women's Health Initiative Randomized Clinical Trials.
Chlebowski RT, Anderson GL, Aragaki AK, Manson JE, Stefanick ML, Pan K, Barrington W, Kuller LH, Simon MS, Lane D, Johnson KC, Rohan TE, Gass MLS, Cauley JA, Paskett ED, Sattari M, Prentice RL. Chlebowski RT, et al. Among authors: paskett ed. JAMA. 2020 Jul 28;324(4):369-380. doi: 10.1001/jama.2020.9482. JAMA. 2020. PMID: 32721007 Free PMC article. Clinical Trial.
Differences in Breast and Colorectal Cancer Screening Adherence Among Women Residing in Urban and Rural Communities in the United States.
Shete S, Deng Y, Shannon J, Faseru B, Middleton D, Iachan R, Bernardo B, Balkrishnan R, Kim SJ, Huang B, Millar MM, Fuemmler B, Jensen JD, Mendoza JA, Hu J, Lazovich D, Robertson L, Demark-Wahnefried W, Paskett ED; Rural Workgroup of the Population Health Assessment in Cancer Center Catchment Areas Initiative. Shete S, et al. Among authors: paskett ed. JAMA Netw Open. 2021 Oct 1;4(10):e2128000. doi: 10.1001/jamanetworkopen.2021.28000. JAMA Netw Open. 2021. PMID: 34605915 Free PMC article.
453 results